BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15474047)

  • 1. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro.
    Kim TD; Paik SR; Yang CH; Kim J
    Protein Sci; 2000 Dec; 9(12):2489-96. PubMed ID: 11206070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
    J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
    Kim TD; Choi E; Rhim H; Paik SR; Yang CH
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease.
    Park JY; Lansbury PT
    Biochemistry; 2003 Apr; 42(13):3696-700. PubMed ID: 12667059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant.
    Ahmad MF; Raman B; Ramakrishna T; Rao ChM
    J Mol Biol; 2008 Jan; 375(4):1040-51. PubMed ID: 18061612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
    Cuervo AM; Stefanis L; Fredenburg R; Lansbury PT; Sulzer D
    Science; 2004 Aug; 305(5688):1292-5. PubMed ID: 15333840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
    Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.
    Klucken J; Shin Y; Hyman BT; McLean PJ
    Biochem Biophys Res Commun; 2004 Dec; 325(1):367-73. PubMed ID: 15522241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of novel peptides derived from the acidic tail of synuclein (ATS) on the aggregation and stability of fusion proteins.
    Park SM; Ahn KJ; Jung HY; Park JH; Kim J
    Protein Eng Des Sel; 2004 Mar; 17(3):251-60. PubMed ID: 15067107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic organization and expression of the human beta-synuclein gene (SNCB).
    Lavedan C; Leroy E; Torres R; Dehejia A; Dutra A; Buchholtz S; Nussbaum RL; Polymeropoulos MH
    Genomics; 1998 Nov; 54(1):173-5. PubMed ID: 9806846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
    McLean PJ; Klucken J; Shin Y; Hyman BT
    Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
    Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
    Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation.
    Munishkina LA; Cooper EM; Uversky VN; Fink AL
    J Mol Recognit; 2004; 17(5):456-64. PubMed ID: 15362105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.